Preclinical Development | SRI International
This is an archived website. Go to the current SRI website

Toggle Menu

Preclinical Development

SRI Biosciences is the only full-service contract research organization based on the West Coast. We work with large and small pharmaceutical and biotechnology clients, including global pharmaceutical companies and start-up biotechnology ventures. We provide services that meet worldwide standards and regulatory requirements for investigational new drug (IND) applications, including services that fully comply with the U.S. Food and Drug Administration’s Good Laboratory Practice (GLP) regulations.

We also serve the nonclinical development needs of the National Institutes for Health (NIH)—holding almost every NIH preclinical services contract—as well as supporting the nonclinical development of countermeasures for the Biomedical Advanced Research and Development Authority (BARDA), Defense Threat Reduction Agency (DTRA) and other government agencies.

Program Overview

We offer:

For biotech and pharmaceutical clients that need specialized expertise in the discovery phase, SRI Biosciences provides discovery services for target research initiatives or as an ongoing development resource.

Other key development services include: